(Q33774628)

29 July 2017

1 reference

title

Glucocorticoid treatment of primary CNS lymphoma (English)

1 reference

29 July 2017

Weller M

1

1 reference

29 July 2017

publication date

1 July 1999

1 reference

Journal of Neuro-Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

43

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

237-239

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006254518848

29 July 2017

exact match

0 references

cites work

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

1 reference

12 December 2020

Prolonged corticosteroid-induced remission in primary central nervous system lymphoma: report of a case and review of the literature

1 reference

12 December 2020

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy

1 reference

12 December 2020

Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature

1 reference

12 December 2020

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

12 December 2020

bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs

1 reference

12 December 2020

Nuclear factor of activated T cells (NFAT) is a possible target for dexamethasone in thymocyte apoptosis.

1 reference

12 December 2020

Primary central nervous system lymphomas--new pathological developments

1 reference

12 December 2020

Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.

1 reference

12 December 2020

Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor

1 reference

12 December 2020

CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.

1 reference

12 December 2020

Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

1 reference

12 December 2020

Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma

1 reference

12 December 2020

The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006254518848

1 reference

Dimensions Publication ID

29 July 2017

1051673174

0 references

1 reference